Kodayake kallon Cervarix na farko ba zai zama wani zaɓi ba don kare kariya daga cututtuka na HPV kamar yadda yake a cikin Gardasil ko Gardasil 9 , hakika ainihin zafin maganin alurar riga kafi ne. Duk da cewa an tsara su don kare su da kawai nau'i biyu na hawan HPV mai tsanani (16 da 18) waɗanda ake danganta da ciwon sankarar mahaifa (a kalla a cikin matan Caucasian ), idan aka kwatanta da sauran maganin da ke dauke da nau'i 4 ko 9, da dama nazarin ya samar da shaidar da ke nuna cewa Cervarix yana da ikon samar da kariya daga wani nau'i mai nauyin cututtukan HPV, wanda ya yiwu, HPV 31, 33, 35, 45, 52, da 58.
Duk da haka, ba kamar Garadsil ba, yana da wuya a kare shi daga kowane ƙananan ƙananan haɗari waɗanda suke haɗuwa da zartar mata .
Cervarix ba shi kadai ba ne a iya iya samar da kariya ta hanyar ketare daga wasu nauyin cutar HPV. Gardasil ya nuna cewa yana da ikon iya kare kariya daga nau'o'in HPV, amma shaida har zuwa yau, ko da yake bai dace ba, ya nuna cewa ƙimar kariya ta kariya bazai da girma kamar yadda Cervarix yake. Bugu da ƙari, wasu masu bincike da suke kwatanta yiwuwar maganin alurar rigakafin biyu don karewa daga nau'in nau'i na HPV sun sami shaidar da Cervarix ta kariya ta iya wucewa fiye da kariya ta Gardasil.
A takaice dai, jimlar jimlar shaida ta nuna cewa ko wanzuwar maganin rigakafi na HPV yana da kyau ... kuma cewa magungunan nan guda biyu ana iya kama su daidai da wancan. Babban amfani da Gardasil shine ikon kare kariya daga zane-zane na jini da kuma irin ciwon daji .
Babban amfani da Cervarix shi ne cewa zai iya bayar da kariya mai karfi da tsayi fiye da wasu nau'o'in ƙwayoyin cuta.
Oh, kuma akwai wani amfani na Cervarix a kan Gardasil, akalla ga ƙananan yawan jama'a. A ƙarshen shekara ta 2013, Hukumar Turai ta amince da rage yawan nau'i biyu na injections, maimakon uku, ga 'yan mata masu shekaru 9 zuwa 14.
An riga an amince da jigon kashi 2 a Amurka, amma idan kuma lokacin da yake, wannan zai iya zama mai motsawa mai karfi don wasu mutane su zabi maganin alurar riga kafi tare da Cervarix kan maganin alurar riga kafi tare da kofar Gardasil. Idan kun kasance wanda ke son injections, ko kuma idan kuna da kudi ko wasu abubuwan da ake zargi game da maganin alurar riga kafi, ana gamawa bayan bayanan biyu zai iya zama mai ban sha'awa fiye da buƙatar dawowa don harbi uku.
Sources:
Bissett SL, Draper E, Myers RE, Godi A, Beddows S. Kwayoyin cuta-neutralizing da Cervarix® ɗan adam papillomavirus maganin rigakafi nuna wani kewayon Alpha-9 inter-type musamman. Alurar riga kafi. 2014 Feb 26, 32 (10): 1139-46. Doi: 10.1016 / j.vaccine.2014.01.008.
Einstein MH, Takacs P, Chatterjee A, Sperling RS, Chakhtoura N, Blatter MM, Lalezari J, David MP, Lin L, Struyf F, Dubin G. Haɗakar immunogenicity na dogon lokaci da aminci na papillomavirus ɗan adam (HPV) -16 / 18 Alurar rigakafin AS04 da maganin rigakafi na HPV-6/11/16/18 a cikin mata masu lafiya masu shekara 18-45: Nazarin binciken binciken ƙarshe na gwaji na farko na III. Hum Lafiya Immunother. 2014; 10 (12): 3435-45. Doi: 10.4161 / hv.36121.
Kohli M, Lawrence D, Haig J, Anonychuk A, Demarteau N. Nunawa tasiri na bambanci a cikin bayanan kariya tsakanin ɗan adam papillomavirus (HPV) -16/18 maganin alurar rigakafin AS04 da kuma papillomavirus ɗan adam (HPV) -6 / 11/16/18 maganin alurar riga kafi a Kanada. BMC Kiwon Lafiyar Jama'a. 2012 Oktoba 13; 12: 872. Doi: 10.1186 / 1471-2458-12-872.
Malagón T, Drolet M, Boily MC, Franco EL, Jit M, Brisson J, Brisson M. Tsarin kare lafiyar mutum biyu na maganin rigakafi na papillomavirus: nazari na yau da kullum da kuma bincike-bincike. Lancet Infect Dis. 2012 Oktoba; 12 (10): 781-9.
Nakalembe M, Banura C, Namujju PB, Mirembe FM. Matakan maganin anti-HPV16 / 18 da anti-HPV31 / 33/35/45/52/58 tsakanin masu maganin rigakafi ta HPV16 / 18 da AS04 da kuma wadanda basu da alurar rigakafin 'yan Uganda kimanin shekaru 10 zuwa 16. Infect Agent Cancer. 2014 Satumba 1; 9: 29. Doi: 10.1186 / 1750-9378-9-29.
Toft L, Tolstrup M, Müller M, Sehr P, Bonde J, Storgaard M, Østergaard L, Søgaard OS. Daidaicin immunogenicity na Cervarix® da Gardasil® mutane maganin rigakafin cutar papillomavirus don maganin maganin maganin rigakafi na HPV-31, HPV-33, da kuma HPV-45 a cikin ƙwayar cutar HIV. Hum Lafiya Immunother. 2014 May, 10 (5): 1147-54. Doi: 10.4161 / hv.27925.